Martin Pharmaceuticals   Report issue

For profit Phase 1
Founded: New York NY United States (2018)

Organization Overview

First Clinical Trial
2018
NCT03737448
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Martin Pharmaceuticals

Active Ingredients

Drugs in Phase 1 Trials (1)

trimetazidine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute-On-Chronic Liver Failure (Phase 1)

End Stage Liver Disease (Phase 1)

Hepatic Insufficiency (Phase 1)

Liver Failure (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1